Integrative Training in Therapeutic Discovery
治疗发现的综合培训
基本信息
- 批准号:7293594
- 负责人:
- 金额:$ 34.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:11qAcademiaAcidsAcuteAdmission activityAdvertisingAdvisory CommitteesAffinityAgeAgonistAgreementAlabamaAldosteroneAlphavirusAlternative TherapiesAmericanAminopeptidaseAmphiregulinAnabolismAnimal ModelAntibioticsAntibodiesAntipsychotic AgentsApoptosisAppendixAreaArkansasArrhythmiaArtsAuthorization documentationBasic ScienceBehavioralBelgiumBindingBiochemicalBiochemistryBiologicalBiological AssayBiological FactorsBiologyBiomedical ResearchBiometryBiomimeticsBiteBlood VesselsBradykininBrainBrazilBreastBreast Cancer CellBupropionBypassCD3 AntigensCalciumCampingCanadaCancer Cell GrowthCancer CenterCancer Center Support GrantCarbonCarcinomaCardiopulmonaryCardiovascular PhysiologyCardiovascular systemCaringCase StudyCatalysisCatalytic RNACatecholaminesCell NucleusCell fusionCell membraneCellsCellular biologyChairpersonChemical ModelsChemicalsChemistryChicagoChildChinaChloride IonChloridesCholineCitiesClassClinicClinicalClinical DataClinical PharmacologyClinical ResearchClinical TrialsClinical Trials DesignCloningCocosCodon NucleotidesCodsCognitionCognition DisordersCognitiveCognitive TherapyCoiled-Coil DomainCollaborationsColonColon CarcinomaColoradoCommunicationCommunitiesComplement 3aComplement 3cComplement 3dComplement component C1sComplexComprehensionComputational BiologyComputer SimulationConditionConsultConsultationsCoronaryCoupledCreatinineCreutzfeldt-Jakob SyndromeCytoplasmic GranulesDNADataDecision MakingDentistsDevelopmentDevice or Instrument DevelopmentDevicesDiabetes MellitusDisciplineDiseaseDockingDoctor of MedicineDoctor of PhilosophyDopamineDoseDouble-Blind MethodDrug AddictionDrug KineticsDrug RegulationsDrug effect disorderE-CadherinERBB2 geneEastern Cooperative Oncology GroupEatingEdemaEducationEducational process of instructingEelsElementsEmergency SituationEndocrineEndopeptidasesEngineeringEnrollmentEnsureEnvironmentEnzymesEpidermal Growth Factor ReceptorEpilepsyEpithelialEpitheliumEquilibriumEtiologyEugeniaEvaluationExtramural ActivitiesFacility Construction Funding CategoryFacultyFailureFamilyFeesFelis catusFellowshipFluorescenceFoundationsFundingGTP-Binding ProteinsGYPA geneGamblingGelatinase BGenesGeneticGenetic ScreeningGenetic TranscriptionGenus ColaGerman populationGermanyGlandGlutamate ReceptorGlutamatesGlycophorin AGlycosidesGoalsGoldline brand of trimethobenzamide monohydrochlorideGovernmentGrantGroup MeetingsGrowthHeadHealthHealth BenefitHearingHospitalsHourHumanHuman MetapneumovirusHybridsHydrocarbonsHydrogen PeroxideHydroxyeicosatetraenoic AcidsIQ3IdahoIllinoisImmuneIn SituIndiaIndianaIndividualIndustryInfectionInhibitory Concentration 50Injection of therapeutic agentInjuryInstitutesInterdisciplinary StudyInternal MedicineInternationalInternetInterviewInvestigationInvestmentsIonsIowaIslets of Langerhans TransplantationIsraelItalyJapanJournalsKAI1 geneKansasKentuckyKineticsKininogenaseKnowledgeKoreaKoreansLabelLaboratoriesLeadLearningLeftLegal patentLettersLevodopaLibrariesLightLipidsLiquid substanceLiteratureLouisianaLungLymphocyteLymphomaMagnetic Resonance ImagingMagnetismMaintenanceMalignant NeoplasmsMalignant neoplasm of pancreasMalondialdehydeMammary glandMaster of ScienceMatrilysinMeasuresMedicalMedical centerMedicineMelanocytic nevusMental DepressionMental disordersMentorsMentorshipMetabolic BiotransformationMetabolismMetabotropic Glutamate ReceptorsMetalloproteasesMetalsMetapneumovirusMethodsMichiganMicrobiologyMirtazapineMississippiMissouriModelingMole the mammalMolecularMolecular BiologyMolecular GeneticsMolecular StructureMolecular and Cellular BiologyMonitorMusMuscarinic Acetylcholine ReceptorMutagenesisMutagensNanostructuresNational Institute of Allergy and Infectious DiseaseNational Institute of Mental HealthNational Research Service AwardsNatureNerve DegenerationNeurobiologyNeurogliaNeurologicNeuronsNeurosciencesNeurotransmittersNon-Steroidal Anti-Inflammatory AgentsNorepinephrineNuclearNucleosidesNumbersObesityObject AttachmentOffice of the DirectorOhioOklahomaOmentumOncology GroupOnline SystemsOperative Surgical ProceduresOralOrganic ChemistryOutcomeOxidative StressPS 5PTGS2 genePan GenusPaperParkinson DiseasePathologyPathway interactionsPatientsPediatricsPeer ReviewPeptide HydrolasesPeptidesPerformancePharmaceutical ChemistryPharmaceutical PreparationsPharmacodynamicsPharmacogeneticsPharmacogenomicsPharmacologic SubstancePharmacologyPharmacy (field)PhasePhase I Clinical TrialsPhilosophyPhosphorusPhosphotransferasesPhysiciansPhysiologicalPhysiologyPisum sativumPlacebo ControlPlacebosPlaque AssayPlasmidsPlayPliabilityPositioning AttributePostdoctoral FellowPotassiumPotassium ChannelPreventionPrevention strategyPrincipal InvestigatorProcessProductivityProgram EvaluationPropertyProstaglandin-Endoperoxide SynthaseProstaglandinsProtease InhibitorProtein ChemistryProtein SubunitsProteinsProteomicsProteusProtocols documentationProtonsPsychiatryPsychotic DisordersPublicationsPurinesPurposePyrenesQiQualifyingRNARNA VirusesRadiationRadiation OncologyRandomizedRangeRateReactionReadinessReagentRecombinantsRecommendationRecordsRecruitment ActivityRegulationRegulator GenesReportingReproduction sporesResearchResearch DesignResearch EthicsResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResidenciesResourcesRespiratory Tract InfectionsRetinalReview CommitteeRibonucleosidesRiskRisperidoneRoboticsRoleRotationRunningS 10SLC2A1 geneSNAP receptorSafetySamplingScanningScheduleSchizophreniaSchoolsScienceScientistSclerosisScreening ResultScreening procedureSeriesSerineSerotoninSignal TransductionSiteSite-Directed MutagenesisSkinSodiumSolutionsSouth TexasSpectrum AnalysisStagingStressStromelysin 1StructureStudentsSulfidesSupport of ResearchSwedenSyndromeSystemSystemic Lupus ErythematosusTJ7TNFRSF5 geneTP53 geneTaiwanTakeda brand of pioglitazone hydrochlorideTechniquesTechnologyTestingTexasTherapeuticTimeTouch sensationToxicologyTrainingTraining ActivityTraining ProgramsTraining SupportTransgenic ModelTranslatingTranslationsTransport ProcessTravelUnited States National Institutes of HealthUniversitiesUtahVaccinesValidationVariantVeteransVirusVisitVisualVocational GuidanceWeekWithdrawalWorkWorld HealthWritingYangYinZebrafishabstractingadductanimationapoptolidinbasecareerchemical geneticschromosome 5q losscollegecomplement C3fconceptcyclooxygenase 1cyclooxygenase 2daydesigndrug discoveryeggexperiencefallsforestfrontiergamma-Aminobutyric Acidgastrointestinalglucagon-like peptide 1high throughput screeninghuman diseaseimprovedin vivoindigo dyeindolineingenolinhibitor/antagonistinterestirinotecanisletlecturerlecturesmacromoleculemalignant breast neoplasmmedical schoolsmembermenmetabotropic glutamate receptor 4metabotropic glutamate receptor 7molecular imagingmolecular modelingmultidisciplinarynamed groupnanoprobeneuroregulationnoradrenaline transporternovelnovel strategiesnovel therapeuticsoncologyoral communicationp27 Cell Cycle Proteinp27 Enzyme Inhibitorpandemic diseasepeptide analogperoxidationphotoactivationposterspre-doctoralpresynapticprofessorprogramsprototypepurinepyreneranpirnasereceptorrepairedresearch studyrespiratory virusresponsesensorserotonin transportersizeskillssmall moleculestructural biologysuccesssymposiumtheoriestooltraffickingtranslational medicinetransmission processtrendtumorvectorvirology
项目摘要
DESCRIPTION (provided by applicant): Understanding of the mechanisms of human disease is expanding at an exponential rate and the NIH Roadmap is challenging scientists to transform this knowledge into tangible health benefits for people. As a result, teams of academic investigators are formulating therapeutic hypotheses and generating the tools with which to test them. This is creating a heed for individuals with interdisciplinary training in translational medicine and chemical biology. Experience at Vanderbilt has identified a mechanism for training graduate students and postdoctoral/fellows in which they are co-mentored by physician-scientists and chemical biologists. The current application formalizes this experience into a program that will provide integrative training in therapeutic discovery. Its goal is to train graduate students and postdoctoral/fellows in the critical steps of therapeutic discovery, including identifying an unmet medical need, considering the molecular basis of the relevant disease, framing a hypothesis for a novel therapeutic approach,- and generating the lead molecules with which to test the hypothesis. Students will be recruited into the program following their first year in graduate school and postdoctoral will be recruited directly into the program. All students and postdocs will take two courses, Foundations of Chemical Biology and Therapeutic Discovery, as well as seminars in chemical biology and clinical pharmacology. The Therapeutic Discovery.course will provide introductory training in drug discovery and describe case studies in the application of an integrative approach to the discovery of new therapeutic strategies and agents. Guest lecturers will participate in the course to highlight the latest advances in disease treatment from the perspective of the individuals who made them. A community of trainees will be developed by participation in a web-based dialog among teams in both core courses, a weekly journal club, a monthly working group, and an annual retreat. Trainees will organize a symposium of extramural speakers as part of the annual retreat. Trainees will be co-mentored by individuals with expertise in translational medicine and chemical biology and their progress will be closely monitored by the Scientific Advisory Committee of the Training Program. The quality of the training provided will be evaluated annually by both an Internal Advisory Committee and an External Advisory Committee. Substantial investments in faculty recruiting and infrastructure coupled with extensive interactions between the College of Arts and Science and the School of Medicine provides a rich environment for integrative training in therapeutic discovery at Vanderbilt.
描述(由申请人提供):对人类疾病机制的理解正在以指数速度扩展,NIH路线图正在挑战科学家将这些知识转化为人们的有形健康益处。因此,学术研究团队正在制定治疗假设,并开发测试这些假设的工具。这为在转化医学和化学生物学方面受过跨学科培训的个人创造了一个机会。在范德比尔特的经验已经确定了一种机制,培养研究生和博士后/研究员,他们是共同辅导的物理学家,科学家和化学生物学家。当前的应用程序将这种经验正式纳入一个计划,该计划将提供治疗发现方面的综合培训。它的目标是培养研究生和博士后/研究员在治疗发现的关键步骤,包括确定未满足的医疗需求,考虑相关疾病的分子基础,为新的治疗方法构建假设,并生成用于测试假设的先导分子。学生将在研究生院的第一年被招募进入该计划,博士后将直接被招募进入该计划。所有学生和博士后将参加两门课程,化学生物学和治疗发现的基础,以及化学生物学和临床药理学的研讨会。治疗发现课程将提供药物发现的入门培训,并描述应用综合方法发现新治疗策略和药物的案例研究。客座讲师将参加课程,从个人的角度突出疾病治疗的最新进展。学员社区将通过参与两个核心课程团队之间的网络对话、每周期刊俱乐部、每月工作组和年度务虚会来发展。作为年度务虚会的一部分,学员将组织一次校外演讲者研讨会。学员将由具有转化医学和化学生物学专业知识的个人共同指导,他们的进展将由培训计划的科学咨询委员会密切监测。所提供培训的质量将每年由内部咨询委员会和外部咨询委员会进行评估。在教师招聘和基础设施的大量投资,加上艺术和科学学院和医学院之间的广泛互动,为范德比尔特的治疗发现综合培训提供了丰富的环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE J. MARNETT其他文献
LAWRENCE J. MARNETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE J. MARNETT', 18)}}的其他基金
Acquisition of an AB Sciex Qtrap 6500 LC/MS/MS System
购买 AB Sciex Qtrap 6500 LC/MS/MS 系统
- 批准号:
8824667 - 财政年份:2015
- 资助金额:
$ 34.38万 - 项目类别:
The Vanderbilt Molecular Target Discovery and Development Center
范德比尔特分子靶标发现和开发中心
- 批准号:
7944019 - 财政年份:2009
- 资助金额:
$ 34.38万 - 项目类别:
The Vanderbilt Molecular Target Discovery and Development Center
范德比尔特分子靶标发现和开发中心
- 批准号:
7853119 - 财政年份:2009
- 资助金额:
$ 34.38万 - 项目类别:
Imaging Tumor Expression of Cyclooxygenase-2
Cyclooxygenase-2 的肿瘤表达成像
- 批准号:
7490266 - 财政年份:2008
- 资助金额:
$ 34.38万 - 项目类别:
CHEMISTRY AND PHARMACOLOGY OF GLYCERYL PROSTAGLANDINS
甘油基前列腺素的化学和药理学
- 批准号:
7209624 - 财政年份:2006
- 资助金额:
$ 34.38万 - 项目类别:
Project 3: Cellular Effects of Aldehydic Products of Lipid Peroxidation
项目3:脂质过氧化醛产物的细胞效应
- 批准号:
8106389 - 财政年份:2005
- 资助金额:
$ 34.38万 - 项目类别:
Project 3: Cellular Effects of Aldehydic Products of Lipid Peroxidation
项目3:脂质过氧化醛产物的细胞效应
- 批准号:
7882605 - 财政年份:2005
- 资助金额:
$ 34.38万 - 项目类别:
相似海外基金
Conference: Rethinking how language background is described in academia and beyond
会议:重新思考学术界及其他领域如何描述语言背景
- 批准号:
2335912 - 财政年份:2024
- 资助金额:
$ 34.38万 - 项目类别:
Standard Grant
ADVANCE Catalyst: Virtual Observatory of Culture for Equity in Academia at the University of Puerto Rico Rio Piedras (VoCEA)
ADVANCE Catalyst:波多黎各 Rio Piedras 大学学术界平等文化虚拟观察站 (VoCEA)
- 批准号:
2214418 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Standard Grant
Comprehensive development strategy of modality-specific "intellectual property" and "cultivation" with an eye on "pharmaceutical affairs" in academia drug discovery
学术界新药研发着眼“药事”的模式“知识产权”与“培育”综合发展策略
- 批准号:
23K02551 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating Research Advancement for Investigators Underrepresented in Academia
加速学术界代表性不足的研究人员的研究进展
- 批准号:
10746315 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Planning: HBCU-UP: Strengthening Data Science Research Capacity and Education Programs through Academia-Industry Partnership
规划:HBCU-UP:通过学术界与工业界合作加强数据科学研究能力和教育计划
- 批准号:
2332161 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Standard Grant
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
从学术界到商界:针对 HPV 相关癌症的新型疗法的开发
- 批准号:
10813323 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
Academics4Rail: Building a Community of Railway Scientific Researchers and Academia for ERJU and Enabling a Network of PhDs (Academia Teaming with Industry)
Academys4Rail:为二院建立铁路科研人员和学术界社区并启用博士网络(学术界与工业界合作)
- 批准号:
10102850 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
EU-Funded
Academics4Rail: Building a community of railway scientific researchers and academia for ERJU and enabling a network of PhDs (academia teaming with industry)
Academys4Rail:为ERJU建立铁路科研人员和学术界社区并建立博士网络(学术界与工业界合作)
- 批准号:
10087488 - 财政年份:2023
- 资助金额:
$ 34.38万 - 项目类别:
EU-Funded
Exploring the overall picture of industry-academia-government collaboration: A spectrum of knowledge transfer through formal and informal channels
探索产学官合作的整体图景:通过正式和非正式渠道进行的一系列知识转移
- 批准号:
22K01692 - 财政年份:2022
- 资助金额:
$ 34.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project
促进道德神经技术学术界与工业界的伙伴关系:利益相关者参与和工具包开发项目
- 批准号:
10655632 - 财政年份:2022
- 资助金额:
$ 34.38万 - 项目类别: